These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23813108)

  • 1. Pattern electroretinogram assessment during ibopamine test in ocular hypertension.
    Giuffrè I; Falsini B; Gari MA; Balestrazzi E
    Eur J Ophthalmol; 2013; 23(6):819-22. PubMed ID: 23813108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparison of topical ibopamine 2% with tonography to identify the outflow resistance in eyes with ocular hypertension.
    Hepsen IF; Yilmaz H; Keskin UC
    Ophthalmic Res; 2005; 37(1):17-22. PubMed ID: 15627837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transiently raised intraocular pressure reveals pattern electroretinogram losses in ocular hypertension.
    Colotto A; Falsini B; Salgarello T; Buzzonetti L; Cermola S; Porrello G
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2663-70. PubMed ID: 8977480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma.
    Azevedo H; Ciarniello MG; Rosignoli MT; Dionisio P; Cunha-Vaz J
    Eur J Ophthalmol; 2003 May; 13(4):370-6. PubMed ID: 12872794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.
    Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):281-9. PubMed ID: 12506086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma.
    Giuffrè I; Taverniti L; Di Staso S
    Eur J Ophthalmol; 2004; 14(6):508-13. PubMed ID: 15638100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positive ibopamine provocative test in normal-tension glaucoma suspects].
    Kniestedt C; Romppainen T; Gloor BP; Stürmer J
    Klin Monbl Augenheilkd; 2007 Apr; 224(4):255-9. PubMed ID: 17458787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases.
    Landers J; Ullrich K; Craig JE
    Clin Exp Ophthalmol; 2015 Dec; 43(9):808-14. PubMed ID: 26140527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of 2% ibopamine on the dilation of patients with pseudoexfoliation syndrome.
    Scuderi GL; Regine F; Perdicchi A; Turtoro A; Contestabile MT
    Eur J Ophthalmol; 2010; 20(1):120-3. PubMed ID: 19882519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibopamine test in healthy and glaucomatous eyes: tonometric and pupillographic study.
    Brogliatti B; Boles Carenini A; Bogetto C; Vadalà G; Grignolo FM; Boles Carenini B
    Acta Ophthalmol Scand Suppl; 2000; (232):13-4. PubMed ID: 11235513
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation between the ibopamine provocative test and the diurnal tension curve in glaucoma patients.
    Magacho L; Costa ML; Reis R; Rios N; de Avila MP
    Arq Bras Oftalmol; 2006; 69(4):477-80. PubMed ID: 17119716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibopamine provocative test and glaucoma: consideration of factors that may influence the examination.
    Magacho L; Lima FE; Costa ML; Fayad FA; Guimarães NL; Avila MP
    Curr Eye Res; 2004 Mar; 28(3):189-93. PubMed ID: 14977521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma.
    Virno M; Sampaolesi R; Pecori Giraldi J; De Gregorio F; Taloni M; Brusini P; Di Staso S; Stecchi G
    J Glaucoma; 2013 Jan; 22(1):5-9. PubMed ID: 21946546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between the 1% and 2% ibopamine provocative test in primary open-angle glaucoma patients: sensitivity, specificity and tolerability.
    Magacho L; Costa ML; Dessimoni A; de Avila MP
    Arq Bras Oftalmol; 2006; 69(5):695-9. PubMed ID: 17187138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibopamine challenge test can be used to differentiate glaucoma suspects from glaucoma patients.
    Ullrich K; Craig JE; Landers J
    Clin Exp Ophthalmol; 2014; 42(4):342-6. PubMed ID: 24034130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ibopamine on aqueous humor production in normotensive humans.
    McLaren JW; Herman DC; Brubaker RF; Nau CB; Wayman LL; Ciarniello MG; Rosignoli MT; Dionisio P
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4853-8. PubMed ID: 14578408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibopamine in glaucoma diagnostics: a new pharmacological provocative test.
    De Gregorio F; Pecori Giraldi J; Pannarale L; Saccucci S; Virno M
    Int Ophthalmol; 1996-1997; 20(1-3):151-5. PubMed ID: 9112180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of near-refraction after administration of ibopamine 2%.
    Giuffré I; Taverniti L; Di Staso S; Balestrazzi E
    Acta Ophthalmol Scand Suppl; 2000; (232):11-2. PubMed ID: 11235511
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between ocular hypertension induced by ibopamine and perimetric defect in primary open-angle glaucoma.
    De Gregorio F; Pecori-Giraldi J; De Stefano C; Virno M
    Eur J Ophthalmol; 1997; 7(2):152-5. PubMed ID: 9243219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostaglandin analogues reduce the ibopamine provocative test specificity in glaucoma].
    Magacho L; Costa ML; Lima FE; Magacho B; Avila MP
    Arq Bras Oftalmol; 2006; 69(2):193-6. PubMed ID: 16699669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.